Quantcast
Connect with us

Far-right leader Le Pen says Trump win ‘good news for France’

Published

on

French far-right leader Marine Le Pen on Wednesday said Donald Trump’s victory in the US presidential election was “good news” for France. “I repeat, the election of Donald Trump is good news for our country,” said Le Pen, who will be the anti-immigration National Front’s candidate in France’s 2017 presidential election. Le Pen, 48, was one…

ADVERTISEMENT


Report typos and corrections to: [email protected].
READ COMMENTS - JOIN THE DISCUSSION
Continue Reading

2020 Election

Democrats and Never-Trumpers gaming out ‘doomsday scenarios’ if president refuses to leave office: report

Published

on

According to a report in the New York Times, Democratic strategists and Never-Trumper conservatives fear Donald Trump will refuse to leave office should he lose in November and are making plans and figuring out their legal options should such an unprecedented state of affairs come to pass.

The report, by the Times' Reid Epstein, begins with one such possible scenario.

Continue Reading

COVID-19

‘Retaliation plain and simple’: Vaccine agency top Doc fired by Trump administration files whistleblower complaint

Published

on

Dr. Rick Bright has retained an attorney and will be filing a whistleblower complaint after the Trump administration fired him from his position as head of the federal agency charged with developing a COVID-19 vaccine. Dr. Bright was moved to a different agency with a narrower focus after he raised concerns over President Donald Trump's obsession with promoting hydroxychloroquine, a malaria drug recent studies found doubles the death rate in coronavirus patients.

Continue Reading
 

COVID-19

Checking blood for coronavirus antibodies – 3 questions answered about serological tests and immunity

Published

on

Coronavirus testing in the United States is moving into a new phase as scientists begin looking into people’s blood for signs they’ve been infected by SARS-CoV-2, the virus that causes COVID-19. This technique is called serological testing.

Virologist Daniel Stadlbauer helped develop a serological test to detect SARS-CoV-2 antibodies and helped transfer it from the research lab to the clinical setting. Epidemiologist Aubree Gordon regularly uses serological assays in her research studies on influenza and dengue fever. She’s now established serological testing for SARS-CoV-2 in her research lab.

Continue Reading
 
 
You need honest news coverage. Help us deliver it. Join Raw Story Investigates for $1. Go ad-free.
close-image